IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals | 524164

Market Closed

₹166.07

₹2.09 (-1.24%)

As on 10/07/26, 12:16 PM

Market Cap4,935.67 CR

Current Price₹166.07

High / Low₹177.9 / 67.19

PE Ratio17.79

Book Value₹57.49

Dividend Yield1.31%

ROCE8.82%

ROE6.12%

Face Value₹2.00

Current Vol.19,27,080

Average Vol.---

ISININE485C01029

PB Ratio1.06

Debt to Equity0.05

Net Profit Margin4.86

Operating Margin10.81

Share Price Chart - IOL Chemicals & Pharmaceuticals Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹168.15₹169.2

₹166.07

Previous CloseToday's Open

₹67.19₹177.9

₹166.07

52W Low52W High

₹169.2Today's Open

₹168.15Previous Close

19,27,080Volume

₹67.1952W Low

₹177.952W High

Ratios

No data available

About Company

IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical
Ingredient (API) and specialty chemicals sectors
Its extensive expertise in both API and specialty chemicals strengthens the business model and opens doors to diversified growth opportunities
Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines
It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories
In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride
The Company is a leader in fostering green chemistry through its extensive production of Ethyl Acetate, a sustainable and environmentally friendly solvent
As one of the largest manufacturers globally, the Company plays a vital role in promoting the adoption of eco-friendly practices in various industries such as pharmaceuticals, printing, flexible packaging, adhesives, surface coatings, flavors, paints & lamination, and essences
The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab
API Unit manufactures Ibuprofen with the installed Capacity of 10 MTPD

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI75.81

SMA 20140.33

SMA 50124.95

SMA 100101.16

SMA 20095.23

SMA 10150.65

MACD_12_26_Days10.62

EMA10Day152.78

EMA20Day143.90

EMA50Day127.18

MACD_12_26_9_Days2.54

EMA100Day111.87

EMA200Day100.66

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth-2.51%

ROE6.13%

EBITDA Margin10.81%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022
Revenue	2,079.21	2,132.79	2,217.11	2,184.02
Interest	14.76	16.10	16.47	8.29
Expenses	1,876.91	1,902.20	1,991.44	1,925.73
Financing Profit	224.71	260.66	251.28	290.33
Financing Margin %	11%	12%	11%	13%
Other Income	22.41	30.07	25.61	32.04
Depreciation	71.99	62.91	46.16	43.26
Profit before tax	137.96	181.65	188.65	224.85
Tax %	27%	26%	26%	25%
Net Profit	101.07	134.43	139.14	167.67
EPS in Rs	3.44	4.58	23.70	28.56

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

07 Jul 2026 12:00 am

Saraswati Commercial (India) Ltd leads gainers in 'B' group

Record Date

Corporate Action

Information

Announcement Day

17 Feb 2026

Interim Dividend (₹1)

Declared an Interim Dividend of Rs. 1/-(50%) per Equity Share of Face Value Rs.2/- each for the Financial Year 2025-26 and fixed 17 February 2026 as the Record Date to determine the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders within 30 days of declaration.

11 Feb 2026

22 Aug 2025

AGM

16 May 2025

11 Mar 2025

Stock Split (1:5)

Face Value Change from 10 To 2

27 Dec 2024

18 Feb 2025

Interim Dividend (₹4)

Outcome of the Board Meeting Declared an Interim Dividend of Rs. 4/- (40%) per Equity Share of Face Value Rs.10/-each for the Financial Year 2024-25 and fixed 18th February 2025 as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend.

12 Feb 2025

23 Aug 2024

AGM

14 May 2024

16 Feb 2024

Interim Dividend (₹5)

The Board of Directors in its meeting held on 6th February 2024 declared an Interim dividend of Rs 5/- (50%) per equity share of face value of Rs 10/-each for the Financial year 2023-24

06 Feb 2024

10 Aug 2023

AGM

28 Apr 2023

17 Feb 2023

Interim Dividend (₹4)

Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated 1st February 2023, we wish to inform you that the Board of Directors in its meeting held on today i.e. 7th February 2023 has inter alia considered and approved: Declared an Interim Dividend of Rs. 4/- (Rupees four only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2022-23.

07 Feb 2023

26 Aug 2022

AGM

30 May 2022

16 Feb 2022

Interim Dividend (₹4)

Pursuant to Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 4th February 2022 has inter alia considered and approved the following: Declared an Interim Dividend of Rs. 4/- (Rupees Four Only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2021-222. Fixed 16th February 2022 (Wednesday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 5th March 2022.

04 Feb 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
168	4,933	34	3	22	0	4.86%
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Frequently Asked Questions

What is Share Price of IOL Chemicals & Pharmaceuticals Ltd?

The current share price of IOL Chemicals & Pharmaceuticals Ltd (IOL Chemicals) is ₹166.07. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd?

The Price-to-Earnings (P/E) ratio of IOL Chemicals & Pharmaceuticals Ltd is 166.07. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of IOL Chemicals & Pharmaceuticals Ltd?

IOL Chemicals & Pharmaceuticals Ltd has a 52-week high of ₹177.90 and a 52-week low of ₹67.19. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of IOL Chemicals & Pharmaceuticals Ltd?

IOL Chemicals & Pharmaceuticals Ltd offers a dividend yield of 0.59%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of IOL Chemicals & Pharmaceuticals Ltd?

The Earnings Per Share (EPS) of IOL Chemicals & Pharmaceuticals Ltd is ₹4.97. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of IOL Chemicals & Pharmaceuticals Ltd?

IOL Chemicals & Pharmaceuticals Ltd has a Return on Equity (ROE) of 6.12%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video